Half-dose verteporfin and half-fluence photodynamic therapy for chronic central serous chorioretinopathy
10.13389/j.cnki.rao.2017.0086
- VernacularTitle:半剂量维替泊芬与半能量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变
- Author:
Weimei MA
;
Xiaoqin LEI
;
Fang TIAN
;
Rongle ZHOU
- Keywords:
photodynamic therapy;
chronic central serous chorioretinopathy;
verteporfin
- From:
Recent Advances in Ophthalmology
2017;37(4):341-343
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the efficacy and safety of half-dose verteporfin and half-fluence photodynamic therapy in chronic central serous chorioretinopathy (CSC).Methods The medical records of 42 patients (42 eyes) with chronic CSC were retrospectively reviewed.According to the difference of drug dose and laser parameters in the course of PDT,the patients were divided into two groups:half-dose group and half-fluence group.Half-dose group:22 patients (22 eyes) received half-dose verteporfin(3 mg· m-2)and standard PDT(83 s,50 J · cm-2).Half-fluence group:20 patients (20 eyes) received full-dose verteporfin (6 mg · m-2) and half-fluence PDT (42 s,25 J · cm-2).Patients were followed up at 1 month,3 months,6 months after PDT.The outcome measures was the proportion of eyes with complete resolution of subretinal fluid(SRF),the changes in best corrected visual acuity (BCVA) and central retinal thickness(CMT).Results At 6 months after PDT,22 eyes(100%) that received half-dose PDT showed complete resolution of SRF,19 eyes(95%)that received half-fulence PDT showed complete resolution of SRF.There was no statistical difference between two groups (P > 0.05).At 6 months after PDT,the mean BCVA improved 7.2 letters in half-dose group and 6.7 letters in half-fluence group.There was no statistical difference compared with the improvement of BCVA between two groups(P > 0.05).In half-dose group,mean baseline central retinal thickness was (351 ± 90) μm,which was decreased to (178 ±55) μm after 6 months,respectively (P < 0.05).In half-fluence group,mean baseline central retinal thickness was (322 ± 96) μm,which was decreased to (181 ± 47) μm after 6 months,respectively (P < 0.05).None of the patients developed retinal pigment epithelium atrophy and CNV.Conclusion Half-dose verteporfm PDT and half-fluence PDT are effective and safe in the treatment of chronic CSC.